SE9902935D0 - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- SE9902935D0 SE9902935D0 SE9902935A SE9902935A SE9902935D0 SE 9902935 D0 SE9902935 D0 SE 9902935D0 SE 9902935 A SE9902935 A SE 9902935A SE 9902935 A SE9902935 A SE 9902935A SE 9902935 D0 SE9902935 D0 SE 9902935D0
- Authority
- SE
- Sweden
- Prior art keywords
- pharmaceutical compositions
- active ingredient
- propylsulphonyl
- phenylethoxy
- benzothiazol
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 125000005975 2-phenylethyloxy group Chemical group 0.000 abstract 1
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 abstract 1
- 208000027771 Obstructive airways disease Diseases 0.000 abstract 1
- 230000001078 anti-cholinergic effect Effects 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 abstract 1
- 239000003149 muscarinic antagonist Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9902935A SE9902935D0 (sv) | 1999-08-18 | 1999-08-18 | Pharmaceutical compositions |
| AU64604/00A AU6460400A (en) | 1999-08-18 | 2000-08-14 | Pharmaceutical compositions |
| PCT/GB2000/003118 WO2001012167A2 (en) | 1999-08-18 | 2000-08-14 | Pharmaceutical compositions comprising a 7-(2-aminoethyl)-benzothiazolone and an anticholinergic muscarinic antagonist |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9902935A SE9902935D0 (sv) | 1999-08-18 | 1999-08-18 | Pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE9902935D0 true SE9902935D0 (sv) | 1999-08-18 |
Family
ID=20416693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9902935A SE9902935D0 (sv) | 1999-08-18 | 1999-08-18 | Pharmaceutical compositions |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU6460400A (sv) |
| SE (1) | SE9902935D0 (sv) |
| WO (1) | WO2001012167A2 (sv) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
| DE10063957A1 (de) * | 2000-12-20 | 2002-06-27 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Dopamin-Agonisten |
| DE10111843A1 (de) | 2001-03-13 | 2002-09-19 | Boehringer Ingelheim Pharma | Verbindungen zur Behandlung von inflammatorischen Erkrankungen |
| US7345060B2 (en) | 2003-11-21 | 2008-03-18 | Theravance, Inc. | Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| TW200738658A (en) | 2005-08-09 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
| TW200745067A (en) | 2006-03-14 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
| TW200833670A (en) | 2006-12-20 | 2008-08-16 | Astrazeneca Ab | Novel compounds 569 |
| GB0702385D0 (en) * | 2007-02-07 | 2007-03-21 | Argenta Discovery Ltd | New combination |
| GB0702458D0 (en) | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | Salts 668 |
| EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| JP2011524896A (ja) | 2008-06-18 | 2011-09-08 | アストラゼネカ・アクチエボラーグ | 呼吸器障害の処置用のベータ２−アドレナリン受容体アゴニストとして作用するベンズオキサジノン誘導体 |
| EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9211172D0 (en) * | 1992-05-27 | 1992-07-08 | Fisons Plc | Compounds |
-
1999
- 1999-08-18 SE SE9902935A patent/SE9902935D0/sv unknown
-
2000
- 2000-08-14 AU AU64604/00A patent/AU6460400A/en not_active Abandoned
- 2000-08-14 WO PCT/GB2000/003118 patent/WO2001012167A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001012167A3 (en) | 2001-09-20 |
| WO2001012167A2 (en) | 2001-02-22 |
| AU6460400A (en) | 2001-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60228857D1 (de) | Amino-phtalazinon derivate, anwendung als kinase inhibitoren, herstellung und pharmazeutische zusammensetzung | |
| FR2808685B1 (fr) | Compositions pharmaceutiques pour administration transdermique d'agents anti-inflammatoires | |
| FR2673538B1 (fr) | Composition a base de 3-[2-(dimethylamino)ethyl]-n-methyl-1h-indole-5 methanesulfonamide pour l'administration buccale. | |
| BR0210122A (pt) | Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo | |
| EA200301165A1 (ru) | Лекарственное средство на основе оксикодона | |
| MXPA04000920A (es) | Derivados de aminoisoxazol activos como inhibidores de la cinasa. | |
| WO2002085909A8 (en) | 9-deazaguanine derivatives as inhibitors of gsk-3 | |
| GEP20053600B (en) | 3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors | |
| BR0108435A (pt) | Formulação e uso de entecavir de baixa dose | |
| CA2229597A1 (en) | Oral fast-dissolving compositions for dopamine agonists | |
| PT1240165E (pt) | Inibidores n-[5-[[[5-alquil-2-oxazolil]metil]tio]-2-tiazolil]carboxamida de quinases dependentes da ciclina | |
| CA2381097A1 (en) | Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents | |
| GEP20074208B (en) | Substituted amides active at the cannabinoid-1 receptor | |
| SE9902935D0 (sv) | Pharmaceutical compositions | |
| GEP20063890B (en) | Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis | |
| ITFI20030058A1 (it) | Formulazioni farmaceutiche contenenti tiazolidinedioni | |
| EE05127B1 (et) | Osadest koosnev komplekt ja ravimpreparaat, mis sisaldavad P2T-retseptori antagonisti v?i selle farmatseutiliselt vastuv?etavat derivaati ja tromboosivastast ainet, ning nende kasutamine meditsiinis | |
| EP1228758A4 (en) | PROHYLACTIC AND THERAPEUTIC AGENTS FOR INFLAMMABLE COLON DISEASES | |
| WO2002011694A3 (en) | Compositions and dosage forms for application in the oral cavity in the treatment of mykoses | |
| ATE161531T1 (de) | Acridine-1,8-dionderivate als therapeutisches mittel | |
| SE9902937D0 (sv) | Pharmaceutical compositions | |
| SE9903995D0 (sv) | New combination | |
| HU9802897D0 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
| SE9902938D0 (sv) | Pharmaceutical compositions | |
| SE9902936D0 (sv) | Pharmaceutical compositions |